Global Prescription Dermatology Therapeutics Market Worth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
52
Global Prescription Dermatology Therapeutics Market Worth USD 53.9 Billion By 2024: Zion Market Research

New York, NY, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Prescription Dermatology Therapeutics Market by Product Type (Psoriasis Drugs, Acne and Rosacea Drugs, Dermatitis and Seborrhea Drugs, Skin Cancer, and Fungal Infection Drugs) and by Distribution Channel (Mail Order Pharmacies, Retail Pharmacies, and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024” . According to the report, the global  prescription dermatology therapeutics market  was valued at approximately USD 28 billion in 2017 and is expected to generate around USD 53.9 billion by 2024, at a CAGR of around 9.9% between 2018 and 2024.

Skin is vulnerable to a wide variety of toxins and microbes as it is the largest and most exposed organ. Prolonged exposure of skin to toxins results in various kinds of skin disorders. This, in turn, fuels the demand for dermatology therapeutics globally. Acne treatment drugs are the most common type of prescription drugs, which are also used to improve the skin’s texture and color. According to the American Academy of Dermatology, acne is the most prevalent skin condition, which affects nearly 50 million Americans annually. Dermatology drugs prescribed to treat baldness are also very common. Hair loss can be caused by various factors, such as hormonal causes, stress, chemotherapy, radiation, etc.

Browse through 62 Tables & 23 Figures spread over 110 Pages and in-depth TOC on “Global Prescription Dermatology Therapeutics Market: By Size, Share, Type, Growth, Analysis and Forecast, 2017—2024”.

Request Free Sample Report of Global Prescription Dermatology Therapeutics Market Report @ https://www.zionmarketresearch.com/sample/pre...ics-market

Psoriasis is a chronic skin disorder caused by an overactive immune system. Inflammation, flaking, and thick, silvery, white, or red skin patches are the most common symptoms of psoriasis. Oral medications, steroid creams, and light therapy are used to treat psoriasis. In psoriasis, skin cells multiply ten times faster than in a normal human. Psoriasis most often develops on elbows, scalp, lower back, and knees. Skin cancer is one of the most common types of cancer, which is caused due to abnormal skin cells growth.

Intensive research to offer therapies for dermatological disorders, increasing number of people affected with dermatological disorders, efforts taken by leading pharmaceutical companies to offer effective treatments, huge investments made in research and development by pharmaceutical companies, and strategic alliances established by companies to speed up the development process of new products are likely to be major growth factors for the global prescription dermatology therapeutics market. However, stringent regulations regarding approvals, the high cost of certain specialized medicines, and the absence of insurance and reimbursement policies might restrict the prescription dermatology therapeutics market globally in the near future.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbro...ics-market

The global prescription dermatology therapeutics market has been segmented into product type and distribution channel. By product type, the prescription dermatology therapeutics market includes psoriasis drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, skin cancer, and fungal infection drugs. Psoriasis drugs held the majority market share in 2017, due to the increasing cases of psoriasis and prolonged treatment period. The distribution channel segment includes mail order pharmacies, retail pharmacies, and hospital pharmacies.

By region, this global market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America represents an established regional market for prescription dermatology therapeutics and is likely to witness noticeable growth in the near future. At the country level, the U.S. is a leading prescription dermatology therapeutics market in North America and is anticipated to register the highest CAGR over the anticipated timeframe. This growth can be attributed to the heavy investments made in research and development by pharmaceutical companies, the growing importance of physical appearance, and unhealthy food habits. Moreover, increasing awareness among the patients and advanced healthcare infrastructure are likely to further fuel the region’s prescription dermatology therapeutics market.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/pr...ics-market

Europe is likely to display a substantial rate of growth in the near future in the market for prescription dermatology therapeutics. This growth can be attributed to increasing expenditure on personal care, rising levels of pollution, and growing incidences of dermatological disorders.

The Asia Pacific prescription dermatology therapeutics market is expected to dominate in the estimated time period. Japan, India, and China are expected to fuel the growth of this regional market. Developments in the Asia Pacific region are expected to be driven by the increasing disposable income and rising stress levels among the young population.

Browse the full  “Prescription Dermatology Therapeutics Market by Product Type (Psoriasis Drugs, Acne and Rosacea Drugs, Dermatitis and Seborrhea Drugs, Skin Cancer, and Fungal Infection Drugs) and by Distribution Channel (Mail Order Pharmacies, Retail Pharmacies, and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”  Report at  https://www.zionmarketresearch.com/report/pre...ics-market

Latin America is anticipated to record swift growth over the estimated time period due to the increasing incidences of dermatological disorders, heavy investments made by major market players, and rising disposable income of the population. The Middle East and Africa region is likely to demonstrate restricted growth due to the scarcity of skilled dermatologists and the absence of latest healthcare infrastructure.

Some key players of the prescription dermatology therapeutics market include Novartis AG, AbbVie, Inc., Amgen, Inc., Janssen Biotech, Inc., Celgene Corporation, Eli Lilly and Company, Pfizer, Inc., Bausch Health Companies, Inc., LEO Pharma A/S, Aurobindo Pharma Ltd., Sun Pharmaceuticals Ltd., and Aclaris Therapeutics, Inc., among others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3688

This report segments the global prescription dermatology therapeutics market into:

Global Prescription Dermatology Therapeutics Market: By Product Type

  • Psoriasis Drugs
  • Acne and Rosacea Drugs
  • Dermatitis and Seborrhea Drugs
  • Skin Cancer
  • Fungal Infection Drugs

Global Prescription Dermatology Therapeutics Market: By Distribution Channel

  • Mail Order Pharmacies 
  • Retail Pharmacies
  • Hospital Pharmacies

Global Prescription Dermatology Therapeutics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research

Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrnewsanalysis.com

Contact Us:

Joel John 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 161

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 101

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 28

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 78

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 161

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Equifax Unveils AI Advisory Service for Lenders' Success

Updated Category News Views 308

Empowering Lenders with Equifax Ignite AI Advisor Equifax has recently launched a transformative tool known as the Equifax Ignite AI Advisor, which is set to revolutionize how lenders operate. This innovative product aims to provide lenders with precise, actionable insights that can significantly improve decision-making processes and account growth. By leveraging advanced...

Continue Reading
Daily Overview: Spain's Stocks Experience Positive Surge

Updated Category News Views 153

Spain's Stock Market Closes on a Positive Note On a recent trading day, stocks in Spain showcased an encouraging uptick, particularly noted after the closing bell rang on Friday. The uptrend was primarily driven by gains in various sectors, which included Consumer Goods, Chemical, Petroleum & Plastic, as well as Telecoms & IT. These sectors played a vital role in...

Continue Reading
AGCO Celebrates Tiina Herlevi's 2025 Women MAKE Award Win

Updated Category News Views 195

AGCO Celebrates Leadership in Manufacturing AGCO, an acknowledged leader in the world of agricultural machinery and precision ag technology, has proudly announced that Tiina Herlevi has been honored with the 2025 Women MAKE Award. This prestigious recognition comes as a testament to her unwavering commitment to excellence and innovation within the manufacturing sector....

Continue Reading
eGain Delivers Impressive Q1 2026 Performance and Guidance

Updated Category News Views 206

Introduction to eGain's Financial Journey With an unwavering commitment to enhancing customer experience (CX) through AI automation, eGain Corporation (NASDAQ: EGAN) continues to make significant strides. Recently, eGain reported its fiscal 2026 first quarter results, showcasing impressive growth metrics and an optimistic outlook for the upcoming quarters. Q1 2026...

Continue Reading
Optimize Your Vehicle with Expert Multi-Point Inspection Services

Updated Category News Views 159

Optimize Your Vehicle with Expert Multi-Point Inspection Services Local drivers can take advantage of a multi-point inspection service at Auction Direct USA, designed to ensure their vehicles remain in peak condition. The Importance of Regular Vehicle Inspections Maintaining your vehicle's health is essential for both safety and longevity. Regular multi-point inspections...

Continue Reading